Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warmed versus room-temperature bupivacaine for axillary block
ACTRN12612000923864Phase 3Completed
- Sponsor
- Military Hospital of Tunis
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupivacaine (2 arms), sponsored by Military Hospital of Tunis. Primary endpoints: Onset time of sensory blockade and Onset time of motor blockade. Started Sep 2012; status: completed.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on ACTRN12612000923864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000923864.